The Future of Precision Medicine, AI, and Biotech with Veronique Bouchet
Podcast by Bio from the Bayou
What if you get the right treatment to the right patients at the right time in even the most complex and costly chronic diseases?
James Zanewicz, Chief Strategy Officer at Tulane University School of Medicine recently sat down with Veronique Bouchet, Chief Medical Officer at PrecisionLife, to discuss how AI-driven precision medicine is driving innovation in healthcare, diagnostics and drug development.
Together, they explore the challenges of tackling chronic diseases that affect billions of patient lives and how new advancements in understanding their complex biology are improving patient outcomes and reducing healthcare costs.
In this episode, you’ll discover:
- New methods for understanding disease onset and progression to accurately predict and prevent chronic diseases.
- How PrecisionLife’s platform addresses major challenges in complex and chronic disease management.
- The key to increasing the rate of success in drug development and reducing global healthcare burdens.
Tune in to learn how PrecisionLife is reshaping healthcare and making a real impact on patients’ lives.
About this podcast
Bio from the Bayou is a leading podcast that explores biotech innovation, business development, and healthcare outcomes, connecting biotech companies, investors, and key opinion leaders to advance medicine, technology, and startup opportunities.
More on this topic
